NEW HAVEN >> This week has yielded a double dose of bad news for Alexion Pharmaceuticals and those who see the drugmaker as a centerpiece of the local and state economy.New Haven-based Alexion announced Tuesday that its chief financial officer, the head of research and development, the top compliance officer and the executive in charge of human resources all will be leaving the company.